Company Monitoring Page for Cytokinetics

latest headlines for company on cafepharma

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision
Fierce Biotech
Fri, 12/20/24 - 11:26 am
Tags:
Cytokinetics, Sanofi, China, aficamten, heart disease, Corxel Pharmaceuticals
FDA kicks off review of Cytokinetics' aficamten for HCM
Pharmaphorum
Tue, 12/3/24 - 09:39 am
Tags:
Cytokinetics, FDA, aficamten, obstructive hypertrophic cardiomyopathy, Bristol Myers Squibb, Camzyos
Bayer lands regional rights to aficamten in Japan deal with Cytokinetics
First Word Pharma
Tue, 11/19/24 - 11:20 am
Tags:
Bayer, Japan, Cytokinetics, aficamten, hypertrophic cardiomyopathy
Eyeing drug launch in 2025, Cytokinetics rolls out HCM awareness campaign
Medical Marketing and Media
Sun, 11/10/24 - 09:30 pm
Tags:
Cytokinetics, hypertrophic cardiomyopathy, aficamten
Investors say 'no bueno' as Cytokinetics stymies M&A prospects with complex Royalty deal
Fierce Biotech
Thu, 05/23/24 - 11:04 am
Tags:
Cytokinetics, Royalty Pharma, aficamten
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
Fierce Biotech
Mon, 05/13/24 - 11:08 am
Tags:
Cytokinetics, Bristol Myers Squibb, Camzyos, aficamten, heart disease
Amgen Emerges as Potential Cytokinetics Suitor as Novartis Pulls Away: Reports
BioSpace
Fri, 01/12/24 - 09:59 am
Tags:
Novartis, Cytokinetics, Amgen, M&A
Novartis drops pursuit of Cytokinetics - source
Reuters
Thu, 01/11/24 - 08:41 pm
Tags:
Novartis, Cytokinetics, M&A
Novartis in advanced talks to buy Cytokinetics
Reuters
Mon, 01/8/24 - 10:29 pm
Tags:
Novartis, Cytokinetics, M&A, aficamten
2 Biotechs That Could Get Bought Out in 2024
Yahoo/Motley Fool
Wed, 01/3/24 - 04:59 pm
Tags:
M&A, BridgeBio Pharma, Cytokinetics
Cytokinetics' heart failure drug improves exercise capacity, sending shares soaring in long-awaited win
Fierce Biotech
Wed, 12/27/23 - 11:06 pm
Tags:
Cytokinetics, cardiomyopathy, aficamten, heart failure
Cytokinetics initiates trial of aficamten to treat nHCM
Clinical Trials Arena
Thu, 09/7/23 - 10:47 am
Tags:
Cytokinetics, clinical trials, aficamten, non-obstructive hypertrophic cardiomyopathy
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
Tags:
R&D, biotech, Merck, sotatercept, Daiichi Sankyo, AstraZeneca, Dato-DXd, Novo Nordisk, CagriSema, Eli Lilly, donanemab, Karuna Therapeutics, Zai Lab, KarXT, Moderna Therapeutics, mRNA-1647, Novartis, iptacopan, Madrigal Pharmaceuticals, resmetirom, Cytokinetics, aficamten, Roche, Chugai, tiragolumab
Unpartnered assets: on the shelf or hidden treasure?
EP Vantage
Thu, 06/15/23 - 09:54 am
Tags:
R&D, ALX Oncology, Argenx, Ascendis Pharma, Cytokinetics, Karuna Therapeutics, Madrigal Pharmaceuticals, Protagonist Therapeutics, Prothena, Ultragenyx Pharmaceutical, Unique Pharma, Ventyx Biosciences
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
Clinical Trials Arena
Mon, 04/24/23 - 11:00 am
Tags:
Cytokinetics, clinical trials, ALS, reldesemtiv, cardiomyopathy, aficamten
Cytokinetics’ pipeline tumble continues after ALS med flops in phase 3 interim look
Fierce Biotech
Sun, 04/2/23 - 04:00 pm
Tags:
Cytokinetics, ALS, clinical trials, reldesemtiv
FDA turns down Cytokinetics’ once-promising heart failure drug omecamtiv
Fierce Pharma
Tue, 02/28/23 - 10:51 pm
Tags:
Cytokinetics, heart failure, FDA, complete response letter, Omecamtiv Mecarbil
FDA advisers nix Cytokinetics' heart failure med, rejecting argument for subgroup use
Fierce Biotech
Tue, 12/13/22 - 11:56 pm
Tags:
FDA, Cytokinetics, heart failure, Omecamtiv Mecarbil
Ahead of adcomm, FDA raises uncertainties on benefit-risk profile of Cytokinetics' potential heart drug
Endpoints
Sun, 12/11/22 - 01:28 pm
Tags:
FDA, Cytokinetics, heart failure, Omecamtiv Mecarbil
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
Tags:
FDA, Mirati Therapeutics, Gilead Sciences, Coherus Biosciences, Roche, Biogen, TG Therapeutics, Ipsen, Novartis, BeiGene, Cytokinetics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.